At the same time, it was worth noting that the ZSCAN20 promoter methylation profile based on gender, age, cancer stage, tumor grade and nodal metastasis status showed significant differences (all P < 0.01) (Figure 4B–4F). This evidence concerns the gene ZSCAN20 and cancer.